BioCentury
ARTICLE | Financial News

Fate Therapeutics completes debt financing

August 11, 2014 7:00 AM UTC

Fate Therapeutics Inc. (NASDAQ:FATE), San Diego, Calif. Business: Gene/Cell therapy, Cancer, Musculoskeletal Date completed: 2014-07-31 Type: Debt financing Raised: $10 million Investor: Silicon Valle...